Regenerative Medicine MarketThe global regenerative medicine industry is experiencing unprecedented growth, with an estimated valuation of USD 13,385.6 million in 2023. The market is projected to ...
GlobalData on MSN2d
USC receives grant for gene therapy targeting glioblastomaThe University of Southern California (USC) has received a $6m grant from the California Institute for Regenerative Medicine ...
News Medical on MSN2d
USC receives $6 million grant for pioneering glioblastoma gene therapyThe California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first ...
The CEO and CTO of the Korean skincare brand speaks about his innovative approach, and the recent launch of a range of ...
The fourth international congress of West Asian and North African (WANA) countries is scheduled to be held from May 3-4 in ...
Rising Demand for 3D Cell Culture Models & Regenerative Therapies Driving Scaffold Technology market Growth ...
A renewed focus on the potentially transformative effect of cell and gene therapies (CGTs) will help businesses developing such treatments to attract investment and persuade policymakers to affect ...
The Terasaki Institute for Biomedical Engineering (TIBI) is pleased to announce their selection of Dr. Cato Laurencin, Chief Executive Officer, Connecticut Convergence Institute, Professor, University ...
ALACHUA, Fla. and TAMPA, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today ...
Coffee is undergoing a transformation driven by three powerful forces: sustainability, health, and innovation. These forces aren’t limited to the coffee industry—they offer critical lessons for ...
Xtant Medical Holdings, Inc.’s XTNT share price has surged by 15.50%, which has investors questioning if this is right time to sell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback